Αρχική World News The EPA’s Limitations On This Toxic Pesticide Put Children At Risk Of...

The EPA’s Limitations On This Toxic Pesticide Put Children At Risk Of Developmental Disabilities

The Environmental Protection Agency’s decision to limit the use of the pesticide chlorpyrifos rather than take it off the market puts the health of children in the United States at risk.

Farmers have been using chlorpyrifos since 1965 under the trade name Lorsban, NPR reports. Chlorpyrifos is commonly used to keep insects and worms out of everything from almond groves to strawberry fields to citrus orchards. Until 2000 it was used indoors for keeping houseflies at bay. That was before the federal governments own environmental scientists linked the toxic chemicals in chlorpyrifos to serious health issues.

Chlorpyrifos is used to keep insects and worms off orange groves.
Source: Adobe Stock/ANDREW NORRIS
Chlorpyrifos is used to keep insects and worms off orange groves.

Residue from chlorpyrifos applications often shows up on unwashed supermarket produce. When the pesticide is ingested, it attacks the nervous system, and can cause dizziness, vomiting and diarrhea. 

Farmers don’t even go near the stuff without special clothing to protect themselves, and the danger doesn’t stop there.

Chlorpyrifos has also been linked to stunted brain growth in children.

Chlorpyrifos residue can wind up on unwashed produce at the supermarket.
Source: Adobe Stock/MNStudio
Chlorpyrifos residue can wind up on unwashed produce at the supermarket.

“Every spring season, children around the U.S. are facing low-dose exposure to this dangerous chemical,” Bonnie Wirtz, a Minnesota mother who was sickened, along with her infant son, by chlorpyrifos, told Chemical & Engineering News. “It is in the air they breathe, the water they drink, and the food they eat.”

Jim Jones, former President Obama’s assistant administrator of the EPA, was responsible for pesticide regulation when the danger to children was first made clear. “Federal scientists followed hundreds of mothers and their newborn children, monitoring their exposure to lots of chemicals,” NPR reports. “One of these studies, by researchers at Columbia University, measured the levels of chlorpyrifos in blood taken from umbilical cords when babies were born.”

Chlorpyrifos has been linked to developmental disabilities in children.
Source: Adobe Stock/New Africa
Chlorpyrifos has been linked to developmental disabilities in children.

That study led to chlorpyrifos being banned in agricultural use in 2015. Five years later, the Trump Administration EPA reversed its stance on chlorpyrifos, citing uncertainty about those previously proven risks, The New York Times reports.

The EPA directly contradicted federal scientists’ conclusions that chlorpyrifos causes developmental disabilities in children. Rather, the agency posted new rules for labeling packages containing chlorpyrifos and recommended wearing personal protection equipment during use and avoiding applications on windy days.

Chlorpyrifos was banned in 2015, but the ban was lifted a few weeks into the Trump Administration.
Source: Adobe Stock/yanadjan
Chlorpyrifos was banned in 2015, but the ban was lifted a few weeks into the Trump Administration.

“By leaving this chemical on the market, we are gambling with the lives of children,” Wirtz said. “It is stealing their futures from them and increasing the amount of health care dollars they will need for treatment. It is breaking the hearts of parents who realize that their children will likely always struggle.”

Despite Trump’s backing, Corteva Agriscience, the largest producer of chlorpyrfios in the U.S., has decided to stop making the product though it may still remain on the market in other forms.

“We don’t feel like it’s viable going forward,” said Susanne Wasson, Corteva’s president of crop protection. “It was a business decision.”

California has banned the sale of chlorpyrifos, but it remains on the market elsewhere.
Source: Adobe Stock/golubovy
California has banned the sale of chlorpyrifos, but it remains on the market elsewhere.

According to the Washington Post, Corteva made the announcement the same day that California banned the sale of chlorphyrifos.

The health of our children is at risk as long as chlorphyrifos remains on the market. Click below to make a difference.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Քաղցկեղն իմ համայնքում՝ Քաղցկեղով երեխաների բուժումը Հայաստանում

«Քաղցկեղն իմ համայնքում»-ը Cancer.Net Blog շարքից է, որը ցույց է տալիս աշխարհում քաղցկեղի ազդեցությունը և թե ինչպես են մարդիկ աշխատում իրենց տարածաշրջանում քաղցկեղով մարդկանց...

Ovarian cancer screening trial did not save lives

“The effort from the start was to save lives of women with ovarian cancer. To build evidence for a screening programme that the NHS...

Cemiplimab Outperforms Investigator’s Choice Chemotherapy in the Second-Line Setting for Recurrent/Metastatic Cervical Carcinoma

Overall survival (OS) was significantly improved with cemiplimab as compared to investigator’s choice of chemotherapy in patients with recurrent/metastatic cervical cancer and progression after...

Expressive Writing, What is It?

One of psychotherapy’s main beliefs is that putting thoughts and feelings into words may produce mental health benefits. Of course, this also applies to cancer...

Sacituzumab Govitecan Earns Full Approval for Triple-Negative Breast Cancer

May 12, 2021, by NCI Staff In triple-negative breast cancer (TNBC), tumor cells don't have estrogen receptors (ER), progesterone receptors (PR), or large amounts of...

‘Will cancer make me infertile?’ – That Cancer Conversation

For the first episode of That Cancer Conversation, we explore infertility and cancer. From teenage body worries to an intercontinental surrogacy story, we chat to...